Brief: EQL Pharma Q1 EBIT Up At SEK 20.5 Mln

EQL Pharma AB

08/08/2025 06:05

Aug 8 (Reuters) - EQL Pharma AB EQL.ST:

Q1 EBIT MARGIN 19%

Q1 REVENUE SEK 107.2 MILLION

Q1 EBIT SEK 20.5 MILLION

Q1 ADJUSTED FREE CASH FLOW SEK -3.2 MILLION

SALES GROWTH FOR FULL YEAR 2025/26 IS FORECAST AT AROUND 30%

Source text: ID:nWkr3TRfpc

Further company coverage: EQL.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))